Soleno Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Soleno Therapeutics, Inc.‘s stocks are currently a part of 13 hedge funds’ portfolios, which represents 24.45% of the total amount of its stocks outstanding. This makes up a total of 2.05M shares of Soleno Therapeutics, Inc.. Compared to the previous quarter, the number fell by -32.26% or -977.75K shares fewer. As for the holding position changes, 15.38% (2) of current hedge fund investors increased the number of shares held, 15.38% (2) of current holders sold a part of the shares held, and 15.38% (2) closed the holdings completely. 4 hedge funds are new holders of Soleno Therapeutics, Inc. stock in Q1 2023, it is 30.77% of total holders.
Hedge funds holding Soleno Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 17 |
|---|---|
| Q3 2018 | 15 |
| Q4 2018 | 17 |
| Q1 2019 | 21 |
| Q2 2019 | 19 |
| Q3 2019 | 19 |
| Q4 2019 | 19 |
| Q1 2020 | 32 |
| Q2 2020 | 63 |
| Q3 2020 | 64 |
| Q4 2020 | 67 |
| Q1 2021 | 62 |
| Q2 2021 | 46 |
| Q3 2021 | 35 |
| Q4 2021 | 33 |
| Q1 2022 | 33 |
| Q2 2022 | 34 |
| Q3 2022 | 17 |
| Q4 2022 | 23 |
| Q1 2023 | 13 |
Hedge funds changes in Soleno Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 5 | 1 | 1 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 6 | 2 | 4 | 1 |
| Q4 2018 | 4 | 4 | 3 | 2 | 4 |
| Q1 2019 | 6 | 6 | 4 | 2 | 3 |
| Q2 2019 | 2 | 6 | 5 | 4 | 2 |
| Q3 2019 | 4 | 6 | 3 | 4 | 2 |
| Q4 2019 | 6 | 6 | 5 | 6 | -4 |
| Q1 2020 | 14 | 6 | 5 | 1 | 6 |
| Q2 2020 | 41 | 15 | 4 | 10 | -7 |
| Q3 2020 | 14 | 25 | 11 | 13 | 1 |
| Q4 2020 | 11 | 21 | 20 | 8 | 7 |
| Q1 2021 | 8 | 20 | 21 | 13 | 0 |
| Q2 2021 | 11 | 9 | 17 | 27 | -18 |
| Q3 2021 | 5 | 9 | 6 | 16 | -1 |
| Q4 2021 | 4 | 6 | 7 | 6 | 10 |
| Q1 2022 | 6 | 9 | 10 | 6 | 2 |
| Q2 2022 | 7 | 6 | 9 | 6 | 6 |
| Q3 2022 | 15 | 0 | 1 | 32 | -31 |
| Q4 2022 | 10 | 3 | 5 | 4 | 1 |
| Q1 2023 | 4 | 2 | 2 | 2 | 3 |
Hedge funds changes in Soleno Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 4,740,000 | 3,043,000 |
| Q3 2020 | 395,000 | 91,000 |
| Q4 2020 | 146,000 | 106,000 |
| Q1 2021 | 179,000 | 320,000 |
| Q2 2021 | 346,000 | 634,000 |
| Q3 2021 | 288,000 | 444,000 |
| Q4 2021 | 126,000 | 43,000 |
| Q1 2022 | 48,000 | 3,000 |
| Q2 2022 | 24,000 | 5,000 |
| Q3 2022 | 37,000 | 24,000 |
| Q4 2022 | 43,560 | 0 |
| Q1 2023 | 0 | 0 |